PRINCE-1: safety and efficacy of atazanavir powder and ritonavir liquid in HIV-1-infected antiretroviral-naïve and -experienced infants and children aged ≥3 months to <6 years

INTRODUCTION: PRINCE-1 is an ongoing prospective, international, multicentre, nonrandomized, two-stage clinical trial assessing safety and efficacy of once-daily atazanavir (ATV) powder boosted with ritonavir (RTV) liquid plus optimized dual nucleoside reverse-transcriptase inhibitor (NRTI) backgrou...

Descripción completa

Detalles Bibliográficos
Autores principales: Strehlau, Renate, Donati, Anamaria Pena, Arce, Pedro Martinez, Lissens, Jurgen, Yang, Rong, Biguenet, Sophie, Cambilargiu, Daniela, Hardy, Hélène, Correll, Todd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463476/
https://www.ncbi.nlm.nih.gov/pubmed/26066346
http://dx.doi.org/10.7448/IAS.18.1.19467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463476/
https://www.ncbi.nlm.nih.gov/pubmed/26066346
http://dx.doi.org/10.7448/IAS.18.1.19467

Ejemplares similares